UNH

UnitedHealth Group just released its Q3 2026 results, and the initial reaction from traders was calm confidence. The stock rose about 1.2% in regular trading to around $409, a measured move rather than a frenzy.

Democrats’ midterm gains have cooled talk of sweeping policy change and pushed investors toward areas where government programs quietly control the revenue tap.

UnitedHealth Group (NYSE:UNH) is facing renewed breakup calls from Senator Elizabeth Warren after its Amedisys acquisition settlement. Warren has urged federal regulators to revisit antitrust concerns around UnitedHealth's growing role…

November 04, 2026--The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.32 per share, to be paid on December 15, 2026, to all shareholders of record of UNH common stock as of the close of…

Mott Capital Management, an investment research and management firm, released its “Thematic Growth Strategy” Q3 2026 investor letter. A copy of the letter can be downloaded here.

https://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176626000266/unh-20260930.htm

Sen. Elizabeth Warren (D-Mass.) blamed President Donald Trump‘s administration for letting UnitedHealth Group Inc. buy Amedisys Inc. for $3.3 billion, arguing it gives the insurer more power to raise costs and deny care.

UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 20 years by 2.57% on an annualized basis producing an average annual return of 11.42%. Currently, UnitedHealth Group has a market capitalization of

Elizabeth Warren is pushing to dismantle UnitedHealth Group just as a nonprofit investor education group moves in the opposite direction, naming the embattled insurer its top undervalued pick for early 2027.

UnitedHealth Group (UNH) is drawing attention after a four day stretch of net ETF buying, capped by US$35.0 million of purchases on October 29, concentrated in large health care and blue chip funds.